| Issuer | % of Class | Filed |
|---|---|---|
|
Scinai Immunotherapeutics Ltd.
13G/A
Amendment 2
09073Q203
|
6.3% |
7/9/2026
Event 4/27/2026
|
|
Scinai Immunotherapeutics Ltd.
13G/A
Amendment 1
09073Q203
|
9.5% |
3/4/2025
Event 2/9/2025
|
|
Scinai Immunotherapeutics Ltd.
13G
09073Q203
|
9.5% |
2/24/2025
Event 2/9/2025
|
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.